Efficacy and Safety of Norketotifen in Uncomplicated Influenza-like Illness
Clinical trial NCT04610047 · COMPLETED
Trial details
- NCT number
- NCT04610047
- Sponsor
- Emergo Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-14
- Primary completion
- 2022-01-25
- Enrollment
- 315
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.